Westlab Pharmacy, Inc. is recalling approximately 309 units of Alprostadil 500 mcg/mL Injectable, ADAA Cataract Drops, and Cyclosporine 1% Human Eye Drops. The recall was initiated because of incorrect product formulation and a lack of necessary process controls during manufacturing. These issues mean the medications may not contain the correct amount of active ingredients or may have been produced in a way that doesn't guarantee safety. If you are using these products, contact your healthcare provider or pharmacist immediately to discuss your treatment and how to return the affected items for a refund.
Incorrect drug formulation can lead to ineffective treatment or serious adverse reactions due to improper dosing. A lack of manufacturing process controls increases the risk that sterile products like injectables and eye drops could be contaminated, potentially causing infections or severe irritation.
Product return and pharmacist consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.